PreveCeutical Medical Inc.
PRVCF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $13,445 | $19,409 | $12,302 | $14,208 |
| - Cash | $74 | $4 | $5 | $59 |
| + Debt | $3,300 | $4,551 | $4,598 | $4,461 |
| Enterprise Value | $16,671 | $23,956 | $16,894 | $18,609 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$3 | -$3 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$556 | -$1,172 | -$678 | -$157 |
| % Margin | – | – | – | – |
| Net Income | -$587 | -$1,255 | -$764 | -$242 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.001 | -0.002 | -0.001 | -0 |
| % Growth | 54.5% | -57.1% | -250% | – |
| Operating Cash Flow | -$374 | -$561 | -$104 | -$66 |
| Capital Expenditures | -$0 | -$3 | -$57 | -$1 |
| Free Cash Flow | -$374 | -$563 | -$162 | -$67 |